Bristol-Myers Squibb to pay Mo. more than $11M to settle Medicaid fraud case

Tuesday, July 15, 2008 | 2:32 p.m. CDT; updated 4:55 p.m. CDT, Tuesday, July 22, 2008

JEFFERSON CITY — Bristol-Myers Squibb has agreed to pay Missouri more than $11 million to resolve claims of Medicaid fraud.

The payment is part of a national settlement in which the drug-maker has agreed to pay hundreds of millions of dollars to 44 states and the federal government. Missouri’s portion of the settlement was announced Tuesday.

The New York-based pharmaceutical giant and former generic subsidiary Apothecon are accused of bilking states by overstating prices for prescription drugs and bribing pharmacies and doctors to use the companies’ medicines.

The drugmakers are also accused of promoting an off-label use for an anti-psychotic drug and engaging in a scheme to lower the rebate payments that the pharmaceutical companies had to pay to the states.

Like what you see here? Become a member.

Show Me the Errors (What's this?)

Report corrections or additions here. Leave comments below here.

You must be logged in to participate in the Show Me the Errors contest.


Leave a comment

Speak up and join the conversation! Make sure to follow the guidelines outlined below and register with our site. You must be logged in to comment. (Our full comment policy is here.)

  • Don't use obscene, profane or vulgar language.
  • Don't use language that makes personal attacks on fellow commenters or discriminates based on race, religion, gender or ethnicity.
  • Use your real first and last name when registering on the website. It will be published with every comment. (Read why we ask for that here.)
  • Don’t solicit or promote businesses.

We are not able to monitor every comment that comes through. If you see something objectionable, please click the "Report comment" link.

You must be logged in to comment.

Forget your password?

Don't have an account? Register here.